Summary
The product Drostanolone Enanthate, sourced from AAS Raw, underwent independent testing to verify its authenticity and potency. The sample, identified by Task Number #32659, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis determined a concentration of 96%+, verifying its quality and purity.
The testing process began on 24 July 2023, with the sample received on 4 August 2023, and analysis completed on 9 August 2023. While the results confirm a high level of quality, the absence of batch-specific information raises questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: AASRaw
- Product Name: 472-61-1
- Active Ingredient: Drostanolone Enanthate
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Raw Powder
Testing Details
- Task Number: #32659
- Testing Ordered: 24 July 2023
- Sample Received: 4 August 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: AAS Raw (Manufacturer)
- Analysis Paid For By: AAS Raw (Manufacturer)
Testing Results
- Specification: Not stated on the report
- Measured Concentration: 96%+
- Accuracy: Verified purity
- Variance: Not specified
Verification Details
- Verification URL: https://janoshik.com/tests/32659_4VZ54I2J8I7T
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the high purity of the tested product but warrants careful evaluation due to the lack of detailed batch information and potential biases. manufacturers or manufacturers often select optimal samples for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Drostanolone Enanthate from AAS Raw has a measured concentration of 96%+, reflecting strong quality for this sample. However, the absence of batch details underscores the importance of additional testing to ensure consistent purity and quality across the product line. This report aims to support educational and harm reduction efforts, helping consumers make informed decisions regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
